Schultze-Seemann W - Search Results

1

[Psychooncology of prostate carcinoma - psychosocial distress and treatment approaches: a systematic review].

Fritzsche K, Diederich D, Schultze-Seemann W. Fritzsche K, et al. Z Psychosom Med Psychother. 2008;54(4):329-53. doi: 10.13109/zptm.2008.54.4.329. Z Psychosom Med Psychother. 2008. PMID: 19049684 Review. German.

2

Mental distress and need for psychosocial support in prostate cancer patients: An observational cross-sectional study.

Baba N, Schrage T, Hartmann A, Baba K, Wuensch A, Schultze-Seemann W, Weis J, Joos A. Baba N, et al. Int J Psychiatry Med. 2021 Jan;56(1):51-63. doi: 10.1177/0091217420938896. Epub 2020 Jun 27. Int J Psychiatry Med. 2021. PMID: 32597270

3

[Limits of surgical therapy of prostate cancer in the aged?].

Schultze-Seemann W. Schultze-Seemann W. Fortschr Med. 1993 Jul 20;111(20-21):343-6. Fortschr Med. 1993. PMID: 8375788 German.

4

[Benign prostatic hyperplasia--choice of therapy in the elderly].

Schultze-Seemann W. Schultze-Seemann W. Fortschr Med. 1993 Sep 10;111(25):394-7. Fortschr Med. 1993. PMID: 7691697 Review. German.

5

Immunotherapy with dendritic cells for prostate cancer.

Thomas-Kaskel AK, Waller CF, Schultze-Seemann W, Veelken H. Thomas-Kaskel AK, et al. Int J Cancer. 2007 Aug 1;121(3):467-73. doi: 10.1002/ijc.22859. Int J Cancer. 2007. PMID: 17514654 Free article. Review.

6

Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer.

Jilg CA, Rischke HC, Reske SN, Henne K, Grosu AL, Weber W, Drendel V, Schwardt M, Jandausch A, Schultze-Seemann W. Jilg CA, et al. J Urol. 2012 Dec;188(6):2190-7. doi: 10.1016/j.juro.2012.08.041. Epub 2012 Oct 18. J Urol. 2012. PMID: 23083862

7

Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only.

Rischke HC, Schultze-Seemann W, Wieser G, Krönig M, Drendel V, Stegmaier P, Krauss T, Henne K, Volegova-Neher N, Schlager D, Kirste S, Grosu AL, Jilg CA. Rischke HC, et al. Strahlenther Onkol. 2015 Apr;191(4):310-20. doi: 10.1007/s00066-014-0763-5. Epub 2014 Oct 18. Strahlenther Onkol. 2015. PMID: 25326142

8

Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.

Jilg CA, Leifert A, Schnell D, Kirste S, Volegova-Neher N, Schlager D, Wieser G, Henne K, Schultze-Seemann W, Grosu AL, Rischke HC. Jilg CA, et al. Radiat Oncol. 2014 Aug 12;9:178. doi: 10.1186/1748-717X-9-178. Radiat Oncol. 2014. PMID: 25112785 Free PMC article.

9

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival.

Thomas-Kaskel AK, Zeiser R, Jochim R, Robbel C, Schultze-Seemann W, Waller CF, Veelken H. Thomas-Kaskel AK, et al. Int J Cancer. 2006 Nov 15;119(10):2428-34. doi: 10.1002/ijc.22097. Int J Cancer. 2006. PMID: 16977630 Free article. Clinical Trial.

10

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Herden J, Ebert T, Schlager D, Pretzer J, Zumbé J, Sommerfeld HJ, Schafhauser W, Kriegmair M, Garcia Schürmann M, Distler F, Baur H, Oberpenning F, Reimann M, Schmidt S, Laabs S, Planz B, Gronau E, Platz G, Göll A, Buse S, Jones J, Haupt G, Waldner M, Heidenreich A, Khaljani E, Rübben H, Schultze-Seemann W, Weib P. Herden J, et al. Urologe A. 2020 Sep;59(9):1082-1091. doi: 10.1007/s00120-020-01192-y. Urologe A. 2020. PMID: 32274545 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page